Joshua D Safer

Joshua D Safer

Icahn School of Medicine at Mount Sinai

H-index: 42

North America-United States

About Joshua D Safer

Joshua D Safer, With an exceptional h-index of 42 and a recent h-index of 31 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of transgender medicine, thyroid disease, skin disease, thyroid hormone resistance.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pubertal status at time of fertility preservation in transgender girls

Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy

Gender-affirming care and endocrine-related cancers

Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy

In a modest transgender cohort following guidelines, few discontinued treatment and regret was not observed

Corrigendum to “Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals”[J. JCTE 2 (2015) 55–60]

Family building in transgender patients: modern strategies with assisted reproductive technology treatment

Estimate and needs of the transgender adult population: the SPoT study

Joshua D Safer Information

University

Position

___

Citations(all)

8926

Citations(since 2020)

6714

Cited By

4302

hIndex(all)

42

hIndex(since 2020)

31

i10Index(all)

83

i10Index(since 2020)

65

Email

University Profile Page

Icahn School of Medicine at Mount Sinai

Google Scholar

View Google Scholar Profile

Joshua D Safer Skills & Research Interests

transgender medicine

thyroid disease

skin disease

thyroid hormone resistance

Top articles of Joshua D Safer

Title

Journal

Author(s)

Publication Date

Pubertal status at time of fertility preservation in transgender girls

Endocrine Practice

Mabel Yau

Neha R Malhotra

John Steever

Eva Baldisserotto

Cathy Lin

...

2024/1/18

Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy

Transgender Health

Micol S Rothman

Ole-Petter R Hamnvik

Caroline Davidge-Pitts

Joshua D Safer

Danit Ariel

...

2024/2/12

Gender-affirming care and endocrine-related cancers

Roger Harty

Joshua D Safer

2024/2/1

Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy

The Journal of Clinical Endocrinology & Metabolism

Nithya Krishnamurthy

Daniel J Slack

Moira Kyweluk

Olivia Cullen

Jerrica Kirkley

...

2024/5

In a modest transgender cohort following guidelines, few discontinued treatment and regret was not observed

The Journal of Clinical Endocrinology & Metabolism

Mabel Yau

Joshua D Safer

2024/2

Corrigendum to “Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals”[J. JCTE 2 (2015) 55–60]

Jamie D Weinand

Joshua D Safer

2024/3

Family building in transgender patients: modern strategies with assisted reproductive technology treatment

Transgender Health

Atoosa Ghofranian

Devora Aharon

Jenna Friedenthal

William J Hanley

Joseph A Lee

...

2024/2/1

Estimate and needs of the transgender adult population: the SPoT study

Journal of Endocrinological Investigation

AD Fisher

M Marconi

G Castellini

JD Safer

S D’Arienzo

...

2024/2/19

Hematospermia in a Transgender Woman with Evidence for Endometrial Tissue in the Prostate

AACE Clinical Case Reports

Janet Coleman-Belin

Uchechukwu O Amakiri

Fang-Ming Deng

Deepthi Hoskoppal

Joshua D Safer

...

2024/1/24

How Should a Transgender Patient’s History of Deep Vein Thrombosis and Smoking Influence Gender-Affirming Health Decision Sharing?

AMA Journal of Ethics

Rebkah Tesfamariam

Joshua D Safer

2023/6/1

Trends in feminizing hormone therapy for transgender patients, 2006–2017

Transgender Health

Adam J Rose

Jaclyn MW Hughto

Michael S Dunbar

Emily K Quinn

Madeline Deutsch

...

2023/4/1

Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer

Daniel R Dickstein

Collin R Edwards

Eric J Lehrer

Elizabeth S Tarras

Matthew Gallitto

...

2023/6

Cancer in transgender and gender-diverse persons: a review

Alberto Giovanni Leone

Dario Trapani

Matthew B Schabath

Joshua D Safer

NFN Scout

...

2023/2/9

SAT398 Pubertal Status And Trends In Gender Affirming Treatment Of Transgender And Gender Diverse Youth

Journal of the Endocrine Society

Cathy Lin

Matthew Oransky

Ralph Fader

Neha R Malhotra

Eva M Baldiserroto

...

2023/10

SAT404 Achieving Both Target Testosterone And Target Estradiol Levels May Not Be Practical In All Trans Feminine Users Of Estradiol-Which To Prioritize?

Journal of the Endocrine Society

Daniel Slack

Nithya Krishnamurthy

Felix Contreras-Castro

Joshua David Safer

2023/10

Update in adult transgender medicine

Alyxandra Ramsay

Joshua D Safer

2023/1/27

Considerations in the care of transgender persons

Sofia B Ahmed

Lauren B Beach

Joshua D Safer

Jaimie F Veale

Cameron T Whitley

2023/6

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy

Cell Reports Medicine

Mabel Yau

Joshua D Safer

2023/1/17

Introduction to the Care of Transgender Persons

Joshua D Safer

2023/7/19

Are Adrenal Androgens Altered by Gender-Affirming Hormone Therapy?

The Journal of Clinical Endocrinology & Metabolism

Tamar Reisman

Joshua D Safer

2023/5/1

See List of Professors in Joshua D Safer University(Icahn School of Medicine at Mount Sinai)

Co-Authors

H-index: 170
Michael F. Holick

Michael F. Holick

Boston University

H-index: 79
Vin Tangpricha

Vin Tangpricha

Emory University

H-index: 68
Eli Coleman

Eli Coleman

University of Minnesota-Twin Cities

H-index: 59
Robert Garofalo

Robert Garofalo

North Western University

academic-engine